BCL2 and cancer: In view of the fact that the acquired imbalance of Bcl-2 proteins is involved in cancer together with our increasing knowledge about the central role of ubiquitin-conjugation governing Bcl-2 abundance and function support the idea that cancer-treatment may strongly benefit from novel therapeutic protocols targeting ubiquitin-regulation of Bcl-2 family.